Magdalena Cerda
Magdalena Cerdá, DrPH
NYU Langone Health - Professor, Department of Population Health and Department of Emergency Medicine
NYU Langone Health - Director, Center on Opioid Epidemiology and Policy
DrPH, Public Health, Harvard University, School of Public Health
MPH, Public Health, Yale University
BS, Communication, Cornell University, Agriculture and Life Sciences
Research Interests
Opioid use disorder, Violence prevention, Firearms, Prescription drugs, Heroin, Drug overdose, Social determinants of injury, Marijuana, Homicide, Suicide
Magdalena Cerdá is Professor of Population Health at New York University Langone Health and Director of the NYU Center on Opioid Epidemiology and Policy. Her work integrates approaches from social and psychiatric epidemiology to examine how social contexts shape violent behavior, substance use and common forms of mental illness. Her expertise extends to the epidemiology and policy determinants of substance use with a particular focus on opioid and marijuana use, including two NIDA-funded studies to examine the impact that prescription opioid policies and marijuana legalization have on opioid prescribing, chronic pain, and opioid overdoses, and a NIDA-funded study to examine the impact that national marijuana legalization in Uruguay has on substance use.  Dr. Cerdá also uses agent-based models to simulate the potential impact of city- and neighborhood-level prevention programs and policies on violence. Prior to joining NYU, Dr. Cerdá served as the Vice-Chancellor’s Endowed Chair on Violence Prevention at UC-Davis and on the faculty at the Columbia Mailman School of Public Health. Dr. Cerdá received her DrPH from Harvard University and was a Robert Wood Johnson Health and Society Scholar at the University of Michigan.
Principal Investigator, Examining the Synergistic Effects of Cannabis and Prescription Opioid Policies on Chronic Pain, Opioid Prescribing, and Opioid Overdose. Active
Principal Investigator, Large Data Spatiotemporal Modeling of Optimal Combinations of Interventions to Reduce Opioid Harm in the United States. Active
Principal Investigator, Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial. Active
Principal Investigator, Health and Social Consequences of Marijuana Legalization. Completed
Principal Investigator, Prescription Drug Monitoring Programs and Opioid-Related Harm. Completed
Principal Investigator, Substance Abuse History, Mental Health and Firearm Violence: From Evidence To Action. Completed


Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerda M (2022).
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019
International Journal of Drug Policy, 110, 103786. doi: 10.1016/j.drugpo.2022.103786.

Kreski NT, Chen Q, Olfson M, Cerda M, Martins SS, Mauro PM, Hasin DS, Keyes KM (2022).
National trends and disparities in bullying and suicidal behavior across demographic subgroups of US adolescents
Journal of the American Academy of Child and Adolescent Psychiatry, 61 (12), 1435-1444. doi: 10.1016/j.jaac.2022.04.011.

Allen B, Jent VA, Cerda M (2022).
Cycles of chronic opioid therapy following mandatory prescription drug monitoring program legislation: A retrospective cohort study
Journal of General Internal Medicine, 37 (16), 4088-4094. doi: 10.1007/s11606-022-07551-z. PMCID: PMC9708972.

Renny MH, Jent V, Townsend T, Cerda M (2022).
Impact of the 2017 FDA Drug Safety Communication on codeine and tramadol dispensing to children
Pediatrics, 150 (5), e2021055887. doi: 10.1542/peds.2021-055887. PMCID: PMC9647590.

Rivera-Aguirre A, Castillo-Carniglia A, Laqueur HS, Rudolph KE, Martins SS, Ramirez J, Queirolo R, Cerda M (2022).
Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay
Addiction, 117 (11), 2866-2877. doi: 10.1111/add.15913.


Castillo-Carniglia A, Ponicki W, Gaidus A, Gruenewald P, Marshall BDL, Fink DS, Martins SS, Rivera-Aguirre A, Wintemute G, Cerda M (2019).
Prescription drug monitoring programs and opioid overdoses: Exploring sources of heterogeneity
Epidemiology, 30 (2), 212-220. doi: 10.1097/EDE.0000000000000950. PMCID: PMC6437666.

Cerda M, Wall M, Feng T, Keyes KM, Sarvet A, Schulenberg J, O'Malley PM, Pacula RL, Galea S, Hasin DS (2017).
Association of state recreational marijuana laws with adolescent marijuana use
JAMA Pediatrics, 171 (2), 142-149. doi: 10.1001/jamapediatrics.2016.3624. PMCID: PMC5365078.

Dr. Cerdá's Google Scholar Profile
Selected Press